IL129422A0 - Pharmaceutical compositions containing lamivudine and zidovudine - Google Patents

Pharmaceutical compositions containing lamivudine and zidovudine

Info

Publication number
IL129422A0
IL129422A0 IL12942297A IL12942297A IL129422A0 IL 129422 A0 IL129422 A0 IL 129422A0 IL 12942297 A IL12942297 A IL 12942297A IL 12942297 A IL12942297 A IL 12942297A IL 129422 A0 IL129422 A0 IL 129422A0
Authority
IL
Israel
Prior art keywords
zidovudine
pharmaceutical compositions
compositions containing
containing lamivudine
lamivudine
Prior art date
Application number
IL12942297A
Other languages
English (en)
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of IL129422A0 publication Critical patent/IL129422A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
IL12942297A 1996-10-31 1997-10-29 Pharmaceutical compositions containing lamivudine and zidovudine IL129422A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9622681.6A GB9622681D0 (en) 1996-10-31 1996-10-31 Pharmaceutical compositions
PCT/EP1997/005953 WO1998018477A2 (en) 1996-10-31 1997-10-29 Pharmaceutical compositions containing lamivudine and zidovudine

Publications (1)

Publication Number Publication Date
IL129422A0 true IL129422A0 (en) 2000-02-17

Family

ID=10802224

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12942297A IL129422A0 (en) 1996-10-31 1997-10-29 Pharmaceutical compositions containing lamivudine and zidovudine

Country Status (44)

Country Link
EP (1) EP0941100B1 (sk)
JP (1) JP2001502718A (sk)
KR (1) KR100551652B1 (sk)
AP (1) AP1067A (sk)
AR (1) AR009135A1 (sk)
AT (1) ATE241364T1 (sk)
AU (1) AU736607B2 (sk)
BG (1) BG64541B1 (sk)
BR (1) BR9712614A (sk)
CA (1) CA2270174A1 (sk)
CO (1) CO4930269A1 (sk)
CY (1) CY2485B1 (sk)
CZ (1) CZ296080B6 (sk)
DE (1) DE69722433T2 (sk)
DK (1) DK0941100T3 (sk)
EA (1) EA002437B1 (sk)
EE (1) EE03806B1 (sk)
ES (1) ES2200204T3 (sk)
GB (1) GB9622681D0 (sk)
GE (1) GEP20022735B (sk)
GT (1) GT199700116A (sk)
HK (1) HK1020880A1 (sk)
HR (1) HRP970569B1 (sk)
HU (1) HU224969B1 (sk)
ID (1) ID18698A (sk)
IL (1) IL129422A0 (sk)
IS (1) IS5024A (sk)
MY (1) MY119513A (sk)
NO (1) NO317163B1 (sk)
NZ (1) NZ335153A (sk)
OA (1) OA11038A (sk)
PA (1) PA8441101A1 (sk)
PE (1) PE10099A1 (sk)
PL (1) PL190349B1 (sk)
PT (1) PT941100E (sk)
SI (1) SI0941100T1 (sk)
SK (1) SK284286B6 (sk)
SV (1) SV1997000090A (sk)
TR (1) TR199900950T2 (sk)
UA (1) UA64725C2 (sk)
UY (1) UY24766A1 (sk)
WO (1) WO1998018477A2 (sk)
YU (1) YU19999A (sk)
ZA (1) ZA979726B (sk)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9622681D0 (en) * 1996-10-31 1997-01-08 Glaxo Group Ltd Pharmaceutical compositions
GB9809213D0 (en) * 1998-04-29 1998-07-01 Glaxo Group Ltd Pharmaceutical compositions
US7074417B2 (en) * 2000-10-13 2006-07-11 Advancis Pharmaceutical Corporation Multiple-delayed release anti-viral product, use and formulation thereof
CZ20041117A3 (cs) * 2002-04-23 2005-04-13 Lupin Limited Dlouhodobě působící kompozice zahrnující zidovudin a lamivudin
WO2004043433A2 (en) * 2002-11-08 2004-05-27 Glaxo Group Limited Pharmaceutical antiviral compositions
US20040224916A1 (en) 2003-01-14 2004-11-11 Gilead Sciences, Inc. Compositions and methods for combination antiviral therapy
AR045841A1 (es) * 2004-09-28 2005-11-16 Richmond Sa Com Ind Y Financie Una composicion farmaceutica solida que comprende al tiazolil metil ester del acido [5s-(5r*, 8r*, 10r*,11r*)] -10- hidroxi-2- metil-5-(1-metiletil)-1-[2-(1-metiletil)-4-tiazolil]-3,6-dioxo-8,11-bis(fenilmetil)-2,4,7,12- tetraazatridecan-13-oico y un procedimiento para prepararla.
US20130115237A1 (en) 2010-06-09 2013-05-09 Vaccine Technologies, Incorporated Therapeutic immunization in hiv infected subjects to augment antiretroviral treatment
AU2013229274A1 (en) 2012-03-05 2014-09-04 Cipla Limited Pharmaceutical antiretroviral combinations comprising lamivudine, festinavir and nevirapine
US20140234415A1 (en) * 2013-02-20 2014-08-21 Abbvie Inc. Tablet Dosage Forms

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4950652A (en) * 1987-03-23 1990-08-21 Hem Research, Inc. dsRNAs for combination therapy in the treatment of viral diseases
WO1992020344A1 (en) * 1991-05-16 1992-11-26 Glaxo Group Limited Antiviral combinations containing nucleoside analogs
GB9110624D0 (en) * 1991-05-16 1991-07-03 Glaxo Group Ltd Combinations
GB9622681D0 (en) * 1996-10-31 1997-01-08 Glaxo Group Ltd Pharmaceutical compositions

Also Published As

Publication number Publication date
WO1998018477A3 (en) 1998-06-18
UY24766A1 (es) 2000-12-29
OA11038A (en) 2002-02-06
EE03806B1 (et) 2002-08-15
BG103435A (en) 2000-04-28
GT199700116A (es) 1999-04-22
KR100551652B1 (ko) 2006-02-13
TR199900950T2 (xx) 1999-07-21
EP0941100A2 (en) 1999-09-15
CY2485B1 (en) 2005-06-03
YU19999A (sh) 2000-10-30
BG64541B1 (bg) 2005-07-29
PE10099A1 (es) 1999-03-02
CA2270174A1 (en) 1998-05-07
EA002437B1 (ru) 2002-04-25
HU224969B1 (en) 2006-04-28
HK1020880A1 (en) 2000-05-26
HRP970569A2 (en) 1998-08-31
KR20000052893A (ko) 2000-08-25
ZA979726B (en) 1999-04-29
NO992091L (no) 1999-06-29
ATE241364T1 (de) 2003-06-15
HRP970569B1 (en) 2004-10-31
DE69722433T2 (de) 2004-04-08
BR9712614A (pt) 1999-10-26
AP1067A (en) 2002-05-01
SK57599A3 (en) 2000-06-12
GEP20022735B (en) 2002-07-25
AU736607B2 (en) 2001-08-02
WO1998018477A2 (en) 1998-05-07
JP2001502718A (ja) 2001-02-27
PL190349B1 (pl) 2005-11-30
PL333143A1 (en) 1999-11-22
IS5024A (is) 1999-04-09
UA64725C2 (uk) 2004-03-15
SV1997000090A (es) 1998-10-07
MY119513A (en) 2005-06-30
EA199900345A1 (ru) 2000-02-28
ES2200204T3 (es) 2004-03-01
SK284286B6 (sk) 2005-01-03
EE9900175A (et) 1999-12-15
NZ335153A (en) 2001-04-27
PT941100E (pt) 2003-10-31
PA8441101A1 (es) 2000-05-24
AP9901519A0 (en) 1999-06-30
AU5314298A (en) 1998-05-22
ID18698A (id) 1998-04-30
CZ296080B6 (cs) 2006-01-11
AR009135A1 (es) 2000-03-08
NO992091D0 (no) 1999-04-29
NO317163B1 (no) 2004-08-30
DE69722433D1 (de) 2003-07-03
GB9622681D0 (en) 1997-01-08
SI0941100T1 (en) 2003-12-31
DK0941100T3 (da) 2003-09-01
HUP0000344A2 (hu) 2001-05-28
CO4930269A1 (es) 2000-06-27
HUP0000344A3 (en) 2002-04-29
EP0941100B1 (en) 2003-05-28
CZ155799A3 (cs) 1999-10-13

Similar Documents

Publication Publication Date Title
IL114622A0 (en) Heteroaryl-oxazolidinones and pharmaceutical compositions containing them
IL121236A0 (en) Cycloalkano-pyridines their preparation and pharmaceutical compositions containing them
IL191904A0 (en) Pharmaceutical and compositions containing a?? fragments
HUP0001309A3 (en) 1-phenyl-4-benzylpiperazines and pharmaceutical compositions containing them
HUP9802999A3 (en) Pharmaceutical composition containing n-propargyl-1-aminoindan
PL335870A1 (en) Hair-care composition
IL135646A0 (en) α-ARYL-N-ALKYLNITRONES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
HUP9900424A2 (hu) Tiazolil-benzfurán-származékok és a vegyületeket tartalmazó gyógyászati készítmények
HUP9901452A3 (en) Bicyclic-aromatic compounds and pharmaceutical compositions containing them
IL128058A0 (en) Illudin analogs and pharmaceutical compositions containing the same
PL331423A1 (en) Muporocin and chlorohexidrin containing compositions
IL117623A (en) Maltitol composition and its preparation
HUP0101701A3 (en) Substituted betha-alanines and pharmaceutical compositions comprising them
IL133928A0 (en) Pharmaceutical composition containing peptichemio
IL116015A0 (en) Iminooxymethyleneanilides thdir preparation and compositions containing them
EP0968983A4 (en) COMPOSITION BASED ON HEXANITROHEXAAZAISOWURTIZITAN AND HEXANITROHEXAAZAISOWURTIZITAN COMPOSITION OF EXPLOSIVES
IL129422A0 (en) Pharmaceutical compositions containing lamivudine and zidovudine
IL131917A (en) Pharmaceutical compositions containing lamivudine
HUP0000460A3 (en) Imidazopyridazines and pharmaceutical compositions thereof
IL112564A0 (en) 1-beta-methyl-carbapenems and compositions containing them
GB9623962D0 (en) Pharmaceutical composition
IL115882A0 (en) Oxazolyl-and thiazolylimidazo-benzo-and thienodiazepines their manufacture and pharmaceutical compositions containing them
HUP0000275A3 (en) Phenanethridinium derivatives and pharmaceutical compositions containing them
HUP9901968A3 (en) 2-thioxotetrahydropyrimidin-4-one derivatives and pharmaceutical compositions containing them
HUP0003528A3 (en) Pharmaceutical compositions containing dihydropolyprenols

Legal Events

Date Code Title Description
MM9K Patent not in force due to non-payment of renewal fees